Lung cancer trials in Netherlands

In Netherlands 142 Also abroad 2744

142 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)
Where
Amsterdam, Nijmegen, Rotterdam, Utrecht, Zwolle
Age
18 years and over
People
168 worldwide
Run by
Amgen Inc.
See details and how to join2026-525489-23-00
Phase 1Taking people
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Where
Amsterdam
Age
18 years and over
People
383 worldwide
Run by
Iambic Therapeutics, Inc
See details and how to joinNCT06253871
Phase 1/2Taking people
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
Where
Amsterdam
Age
18 years and over
People
171 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT06567015 · EU 2023-510203-21-00
No phaseTaking people
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
Where
Leiden
Age
18 years and over
People
2,000 worldwide
Run by
Mark C Burgmans, MD PhD
See details and how to joinNCT07636148
Phase 3Taking people
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer
Where
Amsterdam, Heerlen, Leeuwarden, Maastricht, Nieuwegein
Age
18 years and over
People
355 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2024-515884-69-00
No phaseTaking people
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Where
Amsterdam
Age
18 years and over
People
27
Run by
Amsterdam UMC, location VUmc
See details and how to joinNCT07782164
Phase 1Taking people
A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers
Where
Groningen
Age
18 years to 100 years
People
36
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07117214
Phase 3Not yet taking people in Netherlands
Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?
Where
Rotterdam
Age
18 years and over
People
426 worldwide
Run by
Norges Teknisk-Naturvitenskapelige Universitet NTNU
See details and how to join2026-525513-31-00
Phase 4Taking people
Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab
Where
Amsterdam
Age
18 years and over
People
38
Run by
Idris Bahce
See details and how to joinNCT06908070
Phase 1/2Taking people
A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer
Where
Amsterdam
Age
18 years and over
People
15
Run by
Amsterdam UMC, location VUmc
See details and how to joinNCT05701176 · EU 2024-517960-45-00
Phase 2/3Taking people
Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
Where
Amsterdam
Age
18 years and over
People
34
Run by
Amsterdam UMC, location VUmc
See details and how to joinNCT06457789 · EU 2023-509486-20-00
Phase 1Taking people
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
Where
Amsterdam
People
7 worldwide
Run by
USWM Ct LLC
See details and how to join2024-513033-21-00
Phase 1Taking people
A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refractory Solid Tumours
Where
Nijmegen, Rotterdam
Age
18 years and over
People
138 worldwide
Run by
Deuteroncology
See details and how to join2023-504897-39-00
Phase 1Taking people
A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers
Where
Groningen
Age
18 years and over
People
36
Run by
Novartis Pharma AG
See details and how to join2024-517746-34-00
Phase 3Taking people
Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
Where
Groningen, Maastricht, Rotterdam
Age
18 years and over
People
156 worldwide
Run by
Amgen Inc.
See details and how to join2024-520050-38-00
Phase 2Taking people
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
Where
Amsterdam
Age
18 years and over
People
16
Run by
The Netherlands Cancer Institute
See details and how to joinNCT06222489 · EU 2023-508233-14-00
Phase 3Taking people
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Where
Maastricht, 's-Hertogenbosch, Tilburg
Age
18 years and over
People
540 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00
Phase 1Taking people
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Where
Utrecht
Age
18 years and over
People
434 worldwide
Run by
Amgen
See details and how to joinNCT07094113
Phase 1Taking people
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Where
Nijmegen, Utrecht
Age
18 years to 100 years
People
162 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06562192
Phase 3Taking people
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Where
Arnhem, Rotterdam, 's-Hertogenbosch, Zwolle
Age
18 years and over
People
756 worldwide
Run by
Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06095583
No phaseTaking people
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
Where
Amsterdam
People
100
Run by
The Netherlands Cancer Institute
See details and how to joinNCT07511933
Phase 2Taking people
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
Where
Amsterdam
Age
18 years and over
People
24 worldwide
Run by
Vall D Hebron Institute Of Oncology
See details and how to join2023-506400-99-00
Phase 1Taking people
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Where
Amsterdam
Age
18 years and over
People
714 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00
Phase 1Taking people
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Where
Amsterdam, Groningen
Age
18 years and over
People
914 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00
Phase 3Taking people
A Randomized, Double-Blind, Placebo-Controlled, MultiRegional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy
Where
Arnhem, Rotterdam, Zwolle
Age
18 years and over
People
147 worldwide
Run by
Shanghai Junshi Biosciences Co. Ltd.
See details and how to join2023-507097-41-01